Mutations in TP53 are shown to exist in over 50 % of HNSCC lesions (Argiris et al. 2008) and have been shown to be one of the most common genetic abnormalities in human cancers (Field et al. 1993). This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.